 ; in 2001, it won a UK DTI Link grant for a collaborative R&D project to develop rapid glycoanalysis technology with GlaxoSmithKline and the University of Oxford.The company's focus is to provide products, services for characterisation and quality control of biopharmaceutical glycosylation.Current products include kits and reagents for detailed analysis of N-linked and O-linked glycans by HPLC and mass spectrometry.